Citigroup: Here is What You Need to Know

Citigroup Earnings ReportFrom New York early Monday morning, Citigroup (C) announced its earnings numbers for the second quarter of 2012, and the highlights of the report were generally positive at first, but the bank’s stock has leveled out near its open in early trading. The bank posted net income for the quarter of $2.9 billion (95 cents per share) on revenue of nearly $19 billion. The EPS beat estimtes by 5 cents per share, but the revenue number missed by $120 million. The revenue number was down 7 percent from a year earlier and the EPS was 2 percent smaller than in 2011.

The stock, however, is not close to reflecting the 95 cents per share, as Citigroup stock opened higher but has since lost ground, currently up just about 15 cents per share at about $26.75 in the first hour of the day.

Why such skepticism? The bank’s net income number was down 1 percent from the prior period, even with taking out of the equation the bank’s loss on its 10 percent share in Akbank ($400 million) as well as more than a $200 million gain in CVA/DVA. Net deposits were up 6 percent from Q2 2011 to $914 billion, while loans were up 10 percent to $527 billion from the prior year’s Q2 numbers. However, Citi Holdings loans of $128 billion was a 24-percent decrease, and assets of $191 billion are down 28 percent.  The loan loss reserve release of $984 million was 50 percent less than in the prior year’s Q2.

Vikram Pandit, CEO of Citi, said, “Our core businesses performed well in a difficult environment and are generating solid returns. We had strong growth in both loans and deposits, showed resilience in our markets-facing businesses, and saw record revenues in Transaction Services. We reduced Citi Holdings to approximately 10% of our balance sheet while our capital strength and liquidity continue to be among the best in the industry. We remain focused on execution, managing our expenses and our risk, and serving clients as only we can.”

This news is perceived as mixed by the Street, which doesn’t mean much for Bill Ackman’s Pershing Square and James Dinan’s York Capital Management, for example. At the end of March, Pershing had nearly $1 billion invested in Citigroup (about 12 percent of its portfolio), while York was in for nearly $325 million (about 5 percent) – and had nearly doubled its shareholding stakke in the first quarter of 2012.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!